Mechanisms, Prevention and Treatment of Saphenous Vein Graft Disease

Am J Cardiol. 2021 Sep 1:154:41-47. doi: 10.1016/j.amjcard.2021.05.040. Epub 2021 Jul 10.

Abstract

Saphenous vein grafts are imperfect yet indispensable conduits commonly used for coronary artery bypass grafting. Their degeneration ultimately leading to occlusion results from the pathological response of the vein to altered blood rheology and several types of vascular injury. Surgical techniques minimizing vessel damage, and prolonged antiplatelet and lipid-lowering treatment are established methods of mitigating the degeneration process hence preventing graft occlusions. Percutaneous interventions in degenerated vein grafts carry high risk of embolization, periprocedural myocardial infarction and restenosis. Thus, native vessel should be the preferred treatment target in case of graft failure whenever technically feasible.

Publication types

  • Review

MeSH terms

  • Atherosclerosis / physiopathology
  • Atherosclerosis / prevention & control*
  • Atherosclerosis / therapy
  • Coronary Artery Bypass*
  • Coronary Artery Disease / surgery*
  • Graft Occlusion, Vascular / physiopathology
  • Graft Occlusion, Vascular / prevention & control*
  • Graft Occlusion, Vascular / therapy
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Percutaneous Coronary Intervention
  • Platelet Aggregation Inhibitors / therapeutic use
  • Postoperative Complications / physiopathology
  • Postoperative Complications / prevention & control*
  • Postoperative Complications / therapy
  • Recurrence
  • Saphenous Vein / transplantation*
  • Thrombosis / physiopathology
  • Thrombosis / prevention & control*
  • Thrombosis / therapy

Substances

  • Hypolipidemic Agents
  • Platelet Aggregation Inhibitors